News

Venaxis Announces Termination of Proposed Transactions with Strand Life Sciences

Venaxis®, Inc. announced today that Venaxis, Strand Life Sciences Private Limited (Strand LS) and its U.S. subsidiary Strand Genomics Inc. (SGI), have agreed to terminate the previously announced transactions between the companies.  Read more…


Venaxis Announces Transaction with Strand Life Sciences

Venaxis®, Inc. (Nasdaq: APPY), announced today that it has entered into a series of agreements for a transaction with Strand Life Sciences Private Limited (Strand LS) and its shareholders.  Read more…


2015 Proxy Information and 2014 Annual Report

 Read more…